Cite
HARVARD Citation
Prinzi, N. et al. (n.d.). 1324PThe role of modulation of somatostatin analogues (SSAs) in association to peptide receptor radionuclide therapy (PRRT) after SSAs progression disease (PD) in advanced well-differentiated (WD) entero-pancreatic neuroendocrine tumours (EP-NETs). Annals of oncology. p. . [Online].